{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:20:53Z","timestamp":1777890053499,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.vph.2021.106888","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T03:30:01Z","timestamp":1624678201000},"page":"106888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Exercise-induced pulmonary hypertension in HIV patients: Association with poor clinical and immunological status"],"prefix":"10.1016","volume":"139","author":[{"given":"Rosalinda","family":"Madonna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Fabiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Forniti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Mazzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Menichetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2021.106888_bb0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2021.106888_bb0010","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1378\/chest.118.4.1133","article-title":"HIV-related pulmonary hypertension: analytic review of 131 cases","volume":"118","author":"Mehta","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.vph.2021.106888_bb0015","first-page":"282","article-title":"Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement","volume":"40","author":"Pugliese","year":"2000","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.vph.2021.106888_bb0020","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/000331979804901206","article-title":"Role of human immunodeficiency virus in primary pulmonary hypertension\u2013case reports","volume":"49","author":"Pellicelli","year":"1998","journal-title":"Angiology"},{"key":"10.1016\/j.vph.2021.106888_bb0025","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/383037","article-title":"Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy","volume":"38","author":"Zuber","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vph.2021.106888_bb0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.200704-541OC","article-title":"Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era","volume":"177","author":"Sitbon","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2021.106888_bb0035","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1164\/rccm.200204-330OC","article-title":"Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"167","author":"Nunes","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2021.106888_bb0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1378\/chest.130.1.176","article-title":"Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma","volume":"130","author":"Alkotob","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.vph.2021.106888_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061910","article-title":"Isolated exercise-induced pulmonary hypertension associates with higher cardiovascular risk in scleroderma patients","volume":"9","author":"Madonna","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.vph.2021.106888_bb0050","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1164\/rccm.200610-1498OC","article-title":"Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension","volume":"175","author":"Anthi","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2021.106888_bb0055","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.79.4.863","article-title":"Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease","volume":"79","author":"Himelman","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2021.106888_bb0060","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1378\/chest.06-2430","article-title":"Stress-induced pulmonary systolic hypertension in patients with scleroderma","volume":"131","author":"Callejas","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.vph.2021.106888_bb0065","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2021.106888_bb0070","article-title":"Association of the European Society of Cardiology echocardiographic probability grading for pulmonary hypertension with short and mid-term clinical outcomes after heart valve surgery","volume":"125\u2013126","author":"Madonna","year":"2020","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2021.106888_bb0075","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ejechocard\/jen175","article-title":"Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC)","volume":"9","author":"Sicari","year":"2008","journal-title":"Eur. J. Echocardiogr."},{"key":"10.1016\/j.vph.2021.106888_bb0080","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","author":"Borlaug","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.vph.2021.106888_bb0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13075-015-0673-7","article-title":"Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension","volume":"17","author":"Nagel","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.vph.2021.106888_bb0090","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1183\/09031936.00076009","article-title":"Exercise stress echocardiography for the study of the pulmonary circulation","volume":"35","author":"Argiento","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2021.106888_bb0095","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"Rudski","year":"2010","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.vph.2021.106888_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2008.11.029","article-title":"Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice","volume":"22","author":"Baumgartner","year":"2009","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.vph.2021.106888_bb0105","first-page":"208","article-title":"European guidelines for the diagnosis and management of acute pulmonary embolism","volume":"76","author":"Cagnina","year":"2021","journal-title":"Rev. Med. Liege"},{"key":"10.1016\/j.vph.2021.106888_bb0110","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1253\/circrep.CR-19-0087","article-title":"Significant clinical indexes of exercise-induced pulmonary hypertension in patients with connective tissue disease","volume":"1","author":"Ojima","year":"2019","journal-title":"Circ Rep"},{"key":"10.1016\/j.vph.2021.106888_bb0115","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/QAD.0b013e328354f5a1","article-title":"Prevalence and risk factors associated with pulmonary hypertension in HIV-infected patients on regular follow-up","volume":"26","author":"Quezada","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.vph.2021.106888_bb0120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/QAD.0b013e328331c65e","article-title":"HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era","volume":"24","author":"Degano","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.vph.2021.106888_bb0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.mcp.0000159833.28271.00","article-title":"Noninfectious pulmonary complications of HIV\/AIDS","volume":"11","author":"Kanmogne","year":"2005","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.vph.2021.106888_bb0130","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/aid.2011.0021","article-title":"Human immunodeficiency virus nef signature sequences are associated with pulmonary hypertension","volume":"28","author":"Almodovar","year":"2012","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.vph.2021.106888_bb0135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1189\/jlb.0405194","article-title":"HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells","volume":"79","author":"Caldwell","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"14","key":"10.1016\/j.vph.2021.106888_bb0140","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1161\/01.CIR.0000012754.72951.3D","article-title":"Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor","volume":"105","author":"Atkinson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2021.106888_bb0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0167-0115(98)00069-X","article-title":"HIV envelope protein gp120 induces neuropeptide Y receptor-mediated proliferation of vascular smooth muscle cells: relevance to AIDS cardiovascular pathogenesis","volume":"75-76","author":"Kim","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/j.vph.2021.106888_bb0150","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/QAD.0000000000000124","article-title":"Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection","volume":"28","author":"Parikh","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.vph.2021.106888_bb0155","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cid\/ciq066","article-title":"High prevalence of echocardiographic abnormalities among HIV-infected persons in the era of highly active antiretroviral therapy","volume":"52","author":"Mondy","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vph.2021.106888_bb0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1385\/CT:4:2:117","article-title":"Effects of HIV drug combinations on endothelin-1 and vascular cell proliferation","volume":"4","author":"Hebert","year":"2004","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.vph.2021.106888_bb0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/01.qai.0000228790.40235.0c","article-title":"Antiretrovirals induce direct endothelial dysfunction in vivo","volume":"42","author":"Jiang","year":"2006","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.vph.2021.106888_bb0170","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa035115","article-title":"Expression of human herpesvirus 8 in primary pulmonary hypertension","volume":"349","author":"Cool","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.vph.2021.106888_bb0175","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000002030","article-title":"Drug abuse and HIV-related pulmonary hypertension: double hit injury","volume":"32","author":"Harter","year":"2018","journal-title":"AIDS."},{"key":"10.1016\/j.vph.2021.106888_bb0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12981-015-0078-3","article-title":"HIV related pulmonary arterial hypertension: epidemiology in Africa, physiopathology, and role of antiretroviral treatment","volume":"12","author":"Bigna","year":"2015","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.vph.2021.106888_bb0185","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/303059","article-title":"Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene","volume":"67","author":"Deng","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.vph.2021.106888_bb0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM200108023450503","article-title":"Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia","volume":"345","author":"Trembath","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2021.106888_bb0195","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI200112805","article-title":"Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension","volume":"108","author":"Eddahibi","year":"2001","journal-title":"J. Clin. Invest."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189121000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189121000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:20:20Z","timestamp":1761528020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189121000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":39,"alternative-id":["S1537189121000604"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2021.106888","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exercise-induced pulmonary hypertension in HIV patients: Association with poor clinical and immunological status","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2021.106888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106888"}}